Skip to content
Guess what? Valuesider just got better: smarter and more intuitive.
Pacific Biosciences of California

PACB

Pacific Biosciences of California

Pacific Biosciences of California 13F Holders

PACB Stock Ownership Activity

# of activities:
1
AVG reported price*:
$1.87
Current price*:
-25.66%($1.39)
1 value investing guru has made changes to the Pacific Biosciences of California (PACB) position according to the gurus' 2026 Q1 SEC quarterly report(s). PACB has been completely sold out by 1 guru(s)

Which gurus or hedge funds bought PACB in 2026 Q1?

According to the 2026 Q1 SEC filing(s) Pacific Biosciences of California (PACB) has not been purchased by any super investor.
To see more about who is investing in Pacific Biosciences of California (PACB), please go to the PACB ownership page.
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* AVG reported price: weighted average based on position sizes. Larger holdings have proportionally more influence on the average. This doesn't represent the actual buy or sell price. It is the split-adjusted average price of the securities as of the last day of the reported period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.